Carlsmed, Inc.
$643.5K 1,199 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Volta Medical Inc
Volta Medical Inc reported $642,958.00 across General Payments, Research, and Ownership to 264 physicians and teaching hospitals across 330 transactions.
- $643.0K
- All-tracks total
- 330
- Transactions
- 264
- Recipients
- −$53.8K
- General Payments vs PY2023
Volta Medical Inc reported $642,958.00 across all CMS Open Payments tracks (General + Research + Ownership) to 264 physicians and teaching hospitals in Program Year 2024 - ranking #712 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $220,208.05, averaging $2.4K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer volta-medical-inc Volta Medical Inc
$643.0K · #712/1,925 · 0.0% industry · PY2024
- TOT $643.0K
- RANK #712
- SHARE 0.0%
- TXN 330
- RCP 264
- CAT 3
- GEN $220.2K
- ΔGEN −$53.8K
- TOP1 11.3%
- PY 2024
Volume peers
Nearest volume peer: Carlsmed, Inc. ($643.5K)
Volta Medical Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Volta Medical Inc's CMS-reported General Payments decreased by $53.8K (−19.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: VOLTA MEDICAL INCPY2023: VOLTA MEDICAL INCPY2024: Volta Medical Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $273,963.36
- PY2024
- $220,208.05
What the Data Shows for Volta Medical Inc
In Program Year 2024, Volta Medical Inc reported $642,958.00 in payments to 264 physicians and teaching hospitals across 330 individual transactions, an average of $1.9K per transaction and $2.4K per recipient. That total places Volta Medical Inc at rank #712 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $143.7K, accounting for 65.3% of this company's General Payments and 63 transactions.
General Payment Breakdown by Type
Volta Medical Inc made 3 types of general payments. "Consulting Fee" is the largest category at $143.7K, 65.3% of General Payments.
How Volta Medical Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $143.7K | 63 | 65.3% |
| Travel and Lodging | $62.0K | 17 | 28.2% |
| Food and Beverage | $14.5K | 184 | 6.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $92,458.31 (42.0%) of $220,208.05 in this company's General Payments records across 140 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Volta Medical Inc
The five named recipients with the highest reported General Payments from this company
- 1
Stavros Mountantonakis
$24,872.05 across 11 reported transactions
- 2
Mark Metzl
$18,376.95 across 6 reported transactions
- 3
Anil Rajendra
$17,103.09 across 10 reported transactions
- 4
Andrea Natale
$16,613.20 across 5 reported transactions
- 5
Devi Nair
$15,493.02 across 9 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Volta Medical Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Volta Medical Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Volta Medical Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Canon Medical Systems USA, Inc.
$640.6K 560 recipients
Compare payment profiles
Edap Technomed Inc
$640.3K 2,475 recipients
Compare payment profiles
Wilson Cook Medical Incorporated
$646.8K 196 recipients
Compare payment profiles
Novo Nordisk Health Care AG
$647.6K 208 recipients
Compare payment profiles
Seigla Medical, Inc.
$651.1K 12 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.